SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regulatory Order
Intimation regarding order passed by Statutory Authority02-07-2024
02-07-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issuance of Letter of Confirmation.02-07-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regulatory Order
Intimation regarding Statutory order passed by GST Authority.27-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation regarding newspaper publication26-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Closure of Trading Window
Intimation regarding closure of trading window.25-06-2024
Sun Pharma Finalises Acquisition Of Taro For $347.73 Million
Taro has become a privately held company and is now a wholly owned subsidiary of Sun Pharma.24-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Intimation regarding completion of acquisition of all outstanding shares of TARO24-06-2024
Outperformance of private sector banks may continue for next one year: Sandip Sabharwal
The smaller pharma companies I find it tough to evaluate, so many of them can potentially do well but I do not have the bandwidth to go molecule by molecule and evaluate those companies. But I think Sun Pharma is a decent business model, so we are just holding it for the long term.24-06-2024
Sun Pharma's investigational weight loss drug shows promise in reducing obesity
The study enrolled 24 obese male participants who were divided into two groups: one with a fixed dosage and the other with increasing dosages of GL0034. The drug not only led to significant weight loss but also enhanced insulin sensitivity and reduced glucose levels.22-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma''s GL0034 demonstrates a significant Phase 1 result in an oral presentation at ADA 84th scientific sessions.22-06-2024